Antares Therapeutics

Antares Therapeutics is a biotechnology company developing transformational, first-in-class precision medicines with a focus on validated, undruggable targets in cancer and other serious diseases with large unmet need. Antares’ lead precision oncology program is expected to enter the clinic in 2026, with multiple additional programs in preclinical development.